Biosenta (XCNQ:ZRO) Operating Margin %: -11,966.67% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biosenta Operating Margin %?

Biosenta XCNQ:ZRO +36.36% Operating Margin % is -11,966.67% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 1,954 Consumer Packaged Goods companies, Biosenta ranks worse than 100% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Biosenta's Operating Income for the three months ended in Mar. 2026 was C$-0.36 Mil. Biosenta's Revenue for the three months ended in Mar. 2026 was C$0.00 Mil. Therefore, Biosenta's Operating Margin % for the quarter that ended in Mar. 2026 was -11,966.67%.

Warning Sign:

Biosenta Inc operating margin has been in a 5-year decline. The average rate of decline per year is -78.3%.

The historical rank and industry rank for Biosenta's Operating Margin % or its related term are showing as below:

XCNQ:ZRO' s Operating Margin % Range Over the Past 10 Years
Min: -144600   Med: -36450   Max: -1020
Current: -45333.33


XCNQ:ZRO's Operating Margin % is ranked worse than
100% of 1954 companies
in the Consumer Packaged Goods industry
Industry Median: 5.37 vs XCNQ:ZRO: -45333.33

Biosenta's 5-Year Average Operating Margin % Growth Rate was -78.30% per year.

Biosenta's Operating Income for the three months ended in Mar. 2026 was C$-0.36 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was C$-1.36 Mil.

Warning Sign:

Biosenta Inc has never been profitable in the past 3 years. It lost money every year.


Biosenta  (XCNQ:ZRO) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Biosenta Operating Margin % Related Terms


Biosenta Operating Margin % Historical Data

* Premium members only.

The historical data trend for Biosenta's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosenta Operating Margin % Chart

Biosenta Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,202.38 -119,700.00 -144,600.00 -111,300.00 -132,700.00

Biosenta Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -11,966.67

XCNQ:ZRO vs PG, CL, KVUE: Operating Margin % Comparison

For the Household & Personal Products subindustry, Biosenta's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosenta Operating Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biosenta's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Biosenta's Operating Margin % falls into.



Biosenta Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Biosenta's Operating Margin % for the fiscal year that ended in Sep. 2025 is calculated as

Operating Margin %=Operating Income (A: Sep. 2025 ) / Revenue (A: Sep. 2025 )
=-1.327 / 0.001
=-132,700.00 %

Biosenta's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-0.359 / 0.003
=-11,966.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -11,966.67% mean?
Biosenta (XCNQ:ZRO) has a Operating Margin % of -11,966.67% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Biosenta and its competitors. According to the industry distribution chart, Biosenta ranks #1954 out of 1954 companies in the Consumer Packaged Goods industry.
Is Biosenta's Operating Margin % too high?
Biosenta's current Operating Margin % is -11,966.67%. Based on the distribution chart, Biosenta ranks #1954 out of 1954 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Biosenta's Operating Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Biosenta ranks #1954 out of 1954 companies for Operating Margin %. This places Biosenta in the lower half of its industry. The industry median Operating Margin % is 5.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Consumer Packaged Goods company?
The median Operating Margin % among Consumer Packaged Goods companies is 5.37, based on 1,954 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Biosenta and its competitors. For the Consumer Packaged Goods industry, the median Operating Margin % is 5.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biosenta's current Operating Margin % is -11,966.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosenta stock overvalued right now?
Biosenta (XCNQ:ZRO) has a current Operating Margin % of -11,966.67%. The current Operating Margin % is -11,966.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Biosenta (XCNQ:ZRO), the current Operating Margin % is -11,966.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosenta Business Description

Address 18 Wynford Drive, Suite 704, Toronto, ON, CAN, M3C 3S2
Biosenta Inc develops antimicrobial products that offer environmentally friendly solutions to a global market. The company is dedicated to the advancement of technology that combats microbial growth in various materials. Its proprietary nanoparticle represents a breakthrough in antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. The company is engaged in developing sales for True product lines and the development for commercial applications of its technology to produce an antimicrobial Tri-Filler product.